WORLAND STEPHEN T (President and Chief Executive) received a stock award from EFFECTOR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/16/2023ACC: 0001209191-23-029646
DirectorOfficer· President and Chief Executive
Since Aug 2021
+6.40K
Net shares
Net buyer
$2.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.40K
Price / share
$0.46
Trade value
$2.94K
% of position
2.9%
5/15/2023
221.03K→227.43K
Total
Net shares
+6.40K
Net value
$2.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2023 | A · Award | +6.40K | $0.46 | $2.94K | 2.9% | 221.03K | 227.43K |
| Total | +6.40K | $2.94K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned562.34K
Total
562.34K indirect562.34K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 562.34K | Indirect |
| Total | 562.34K | 562.34K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported